However, this study included cancer-associated stroke with relatively heterogeneous traits (e.g., including hematologic malignancy, nonactive cancer with stably controlled states, treated by both IV-tPA and intra-arterial thrombectomy). The gene discussed is PLAT; the disease is cancer.